Literature DB >> 7664503

Cardiac consequences of diabetes mellitus.

A Shehadeh1, T J Regan.   

Abstract

A variety of disciplines including noninvasive and invasive cardiac methodologies, as well as epidemiologic studies, have provided information that has altered our view on the relation of diabetes to cardiac disease. Instead of an exclusive focus on coronary artery disease, it is now recognized that heart muscle can be independently involved in diabetic patients. In diabetics without known cardiac disease, abnormalities of left ventricular mechanical function have been demonstrated in 40 to 50% of subjects, and it is primarily a diastolic phenomenon. Left ventricular hypertrophy may eventually appear in the absence of hypertension. The diastolic dysfunction appears related to interstitial collagen deposition, largely attributable to diminished degradation. The presence of even moderate obesity intensifies the abnormality. Reversibility of this process is not readily achieved with chronic insulin therapy. Experimental studies have indicated normalization of the collagen alteration by endurance training, begun relatively early in the disease process. General measures of management include the control of other cardiac risk factors and a reasonable program of physical activity. The high mortality during an initial acute myocardial infarction has been attributed to heart failure, which is managed as in nondiabetic patients. Recently, the early introduction of aspirin, thrombolysis, and beta-adrenergic blockade has reduced mortality during the initial infarction. Chronic use of the latter agent over the subsequent years has also proven to be more beneficial in diabetic patients with acute myocardial infarction compared with nondiabetic patients.

Entities:  

Mesh:

Year:  1995        PMID: 7664503     DOI: 10.1002/clc.4960180604

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  29 in total

Review 1.  Diastolic dysfunction: a link between hypertension and heart failure.

Authors:  Sophie Lalande; Bruce D Johnson
Journal:  Drugs Today (Barc)       Date:  2008-07       Impact factor: 2.245

2.  Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice.

Authors:  R Anzawa; M Bernard; S Tamareille; D Baetz; S Confort-Gouny; J P Gascard; P Cozzone; D Feuvray
Journal:  Diabetologia       Date:  2006-01-20       Impact factor: 10.122

3.  Type I and II models of diabetes produce different modifications of K+ currents in rat heart: role of insulin.

Authors:  Y Shimoni; H S Ewart; D Severson
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

4.  Left bundle branch block in type 2 diabetes mellitus: a sign of advanced cardiovascular involvement.

Authors:  Eliscer Guzman; Narpinder Singh; Ijaz A Khan; Andreas P Niarchos; Cherian Verghese; Cesare Saponieri; Harinder K Singh; Ramesh M Gowda; Balendu C Vasavada; Ronny A Cohen
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

5.  [ESC/EASD joint guidelines on diabetes and cardiovascular diseases].

Authors:  Wolfgang Motz; Rolf Dörr
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

6.  Causes and characteristics of diabetic cardiomyopathy.

Authors:  Jianxun Wang; Ye Song; Qianwen Wang; Patricia M Kralik; Paul N Epstein
Journal:  Rev Diabet Stud       Date:  2006-11-10

7.  Reduced volume-regulated outwardly rectifying anion channel activity in ventricular myocyte of type 1 diabetic mice.

Authors:  Shintaro Yamamoto; Kunihiko Ichishima; Tsuguhisa Ehara
Journal:  J Physiol Sci       Date:  2008-12-26       Impact factor: 2.781

Review 8.  Obesity-related cardiorenal disease: the benefits of bariatric surgery.

Authors:  Wiebke Fenske; Thanos Athanasiou; Leanne Harling; Christiane Drechsler; Ara Darzi; Hutan Ashrafian
Journal:  Nat Rev Nephrol       Date:  2013-08-06       Impact factor: 28.314

Review 9.  Hopes, disillusions and more hopes from vitamin C.

Authors:  M C De Tullio; O Arrigoni
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

10.  Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.

Authors:  Ioannis Karakikes; Maengjo Kim; Lahouaria Hadri; Susumu Sakata; Yezhou Sun; Weijia Zhang; Elie R Chemaly; Roger J Hajjar; Djamel Lebeche
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.